Graft versus host disease following transfusion of normal blood products to patients with malignancies

A. Kessinger, James Olen Armitage, Lynell Warren Klassen, J. D. Landmark, J. M. Hayes, A. E. Larsen, D. T. Purtilo

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

A patient undergoing treatment with cytotoxic chemotherapy for Hodgkin's disease developed graft versus host disease (GVHD) following a transfusion of packed red cells. This is the 28th reported patient with a malignancy who did not have a bone marrow transplant and developed GVHD after transfusion of normal blood or blood products. All patients had received cytotoxic chemotherapy prior to acquiring GVHD. The underlying malignancies included lymphoma, acute leukemia, neuroblastoma, rhabdomyosarcoma, and glioblastoma. Twenty‐three of the 28 patients died of GVHD. The incidence of transfusion‐related GVHD in this patient population is low but the illness is often fatal as treatment is largely ineffective. Transfusion‐related GVHD can be prevented by irradiating all blood products with 1500 rad prior to administration.

Original languageEnglish (US)
Pages (from-to)206-209
Number of pages4
JournalJournal of Surgical Oncology
Volume36
Issue number3
DOIs
StatePublished - Nov 1987

Fingerprint

Graft vs Host Disease
Blood Transfusion
Neoplasms
Drug Therapy
Rhabdomyosarcoma
Glioblastoma
Hodgkin Disease
Neuroblastoma
Lymphoma
Leukemia
Bone Marrow
Transplants
Incidence
Therapeutics
Population

Keywords

  • GVHD
  • immunodeficiency
  • transfusion

ASJC Scopus subject areas

  • Surgery
  • Oncology

Cite this

Graft versus host disease following transfusion of normal blood products to patients with malignancies. / Kessinger, A.; Armitage, James Olen; Klassen, Lynell Warren; Landmark, J. D.; Hayes, J. M.; Larsen, A. E.; Purtilo, D. T.

In: Journal of Surgical Oncology, Vol. 36, No. 3, 11.1987, p. 206-209.

Research output: Contribution to journalArticle

Kessinger, A. ; Armitage, James Olen ; Klassen, Lynell Warren ; Landmark, J. D. ; Hayes, J. M. ; Larsen, A. E. ; Purtilo, D. T. / Graft versus host disease following transfusion of normal blood products to patients with malignancies. In: Journal of Surgical Oncology. 1987 ; Vol. 36, No. 3. pp. 206-209.
@article{25a39d58d58b4ac7a6c7ceda6f5db26c,
title = "Graft versus host disease following transfusion of normal blood products to patients with malignancies",
abstract = "A patient undergoing treatment with cytotoxic chemotherapy for Hodgkin's disease developed graft versus host disease (GVHD) following a transfusion of packed red cells. This is the 28th reported patient with a malignancy who did not have a bone marrow transplant and developed GVHD after transfusion of normal blood or blood products. All patients had received cytotoxic chemotherapy prior to acquiring GVHD. The underlying malignancies included lymphoma, acute leukemia, neuroblastoma, rhabdomyosarcoma, and glioblastoma. Twenty‐three of the 28 patients died of GVHD. The incidence of transfusion‐related GVHD in this patient population is low but the illness is often fatal as treatment is largely ineffective. Transfusion‐related GVHD can be prevented by irradiating all blood products with 1500 rad prior to administration.",
keywords = "GVHD, immunodeficiency, transfusion",
author = "A. Kessinger and Armitage, {James Olen} and Klassen, {Lynell Warren} and Landmark, {J. D.} and Hayes, {J. M.} and Larsen, {A. E.} and Purtilo, {D. T.}",
year = "1987",
month = "11",
doi = "10.1002/jso.2930360311",
language = "English (US)",
volume = "36",
pages = "206--209",
journal = "Journal of Surgical Oncology",
issn = "0022-4790",
publisher = "Wiley-Liss Inc.",
number = "3",

}

TY - JOUR

T1 - Graft versus host disease following transfusion of normal blood products to patients with malignancies

AU - Kessinger, A.

AU - Armitage, James Olen

AU - Klassen, Lynell Warren

AU - Landmark, J. D.

AU - Hayes, J. M.

AU - Larsen, A. E.

AU - Purtilo, D. T.

PY - 1987/11

Y1 - 1987/11

N2 - A patient undergoing treatment with cytotoxic chemotherapy for Hodgkin's disease developed graft versus host disease (GVHD) following a transfusion of packed red cells. This is the 28th reported patient with a malignancy who did not have a bone marrow transplant and developed GVHD after transfusion of normal blood or blood products. All patients had received cytotoxic chemotherapy prior to acquiring GVHD. The underlying malignancies included lymphoma, acute leukemia, neuroblastoma, rhabdomyosarcoma, and glioblastoma. Twenty‐three of the 28 patients died of GVHD. The incidence of transfusion‐related GVHD in this patient population is low but the illness is often fatal as treatment is largely ineffective. Transfusion‐related GVHD can be prevented by irradiating all blood products with 1500 rad prior to administration.

AB - A patient undergoing treatment with cytotoxic chemotherapy for Hodgkin's disease developed graft versus host disease (GVHD) following a transfusion of packed red cells. This is the 28th reported patient with a malignancy who did not have a bone marrow transplant and developed GVHD after transfusion of normal blood or blood products. All patients had received cytotoxic chemotherapy prior to acquiring GVHD. The underlying malignancies included lymphoma, acute leukemia, neuroblastoma, rhabdomyosarcoma, and glioblastoma. Twenty‐three of the 28 patients died of GVHD. The incidence of transfusion‐related GVHD in this patient population is low but the illness is often fatal as treatment is largely ineffective. Transfusion‐related GVHD can be prevented by irradiating all blood products with 1500 rad prior to administration.

KW - GVHD

KW - immunodeficiency

KW - transfusion

UR - http://www.scopus.com/inward/record.url?scp=0023543707&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023543707&partnerID=8YFLogxK

U2 - 10.1002/jso.2930360311

DO - 10.1002/jso.2930360311

M3 - Article

C2 - 3316850

AN - SCOPUS:0023543707

VL - 36

SP - 206

EP - 209

JO - Journal of Surgical Oncology

JF - Journal of Surgical Oncology

SN - 0022-4790

IS - 3

ER -